Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women

Combined Natural Molecules Improve Markers of Metabolic Syndrome and Climacteric in Menopausal Women

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06057896

Enrollment

200

Registered

2023-09-28

Start date

2022-09-30

Completion date

2023-08-15

Last updated

2023-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Climacteric Syndrome, Menopause, Metabolic Syndrome

Brief summary

The study collected retrospective data from the assumption of combined natural molecules in menopausal women with metabolic syndrome

Interventions

DIETARY_SUPPLEMENTinositol, phytoestrogens, cocoa polyphenols

myo-inositol, soy isoflavones and cocoa polyphenols

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

45 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* menopause * diagnosis of metabolic syndrome

Exclusion criteria

* pharmacologically-induced menopause * hormonal therapies * sensitizing insulin therapies * cancer patient or ex-cancer patient

Design outcomes

Primary

Measure	Time frame	Description
Body mass index	[0, 6 months]	Change of body weight

Secondary

Measure	Time frame	Description
Climacteric	[0, 6 months]	Changes of number of flushes
Climateric	[0, 6 months]	Changes of intensity of flushes measured through questionnaire

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026